CDC Advisory Panel Considers Changes to Childhood Vaccine Schedule Amid Leadership Shifts
The CDC's Advisory Committee on Immunization Practices is reviewing potential modifications to the childhood vaccination schedule, including the hepatitis B vaccine for newborns, following recent leadership changes and policy shifts under Health Secretary Robert F. Kennedy Jr.
The Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) is convening to evaluate potential changes to the childhood vaccination schedule, including the hepatitis B vaccine administered to newborns. This review follows significant leadership changes and policy shifts under Health Secretary Robert F. Kennedy Jr.
In June 2025, Secretary Kennedy dismissed all 17 members of the ACIP, appointing new members, some of whom have previously expressed skepticism about vaccines. This move has raised concerns among public health experts about the future direction of vaccine policy.
The committee is expected to discuss the timing of the hepatitis B vaccine, currently recommended within the first 24 hours of life. Some argue that universal vaccination at birth may be unnecessary if the mother does not carry the virus, which is primarily transmitted through blood or sexual contact. However, the American Academy of Pediatrics emphasizes that immunizing newborns is critical to reducing chronic hepatitis B later in life.
Additionally, the ACIP plans to review the cumulative health effects of the entire childhood vaccination schedule, which includes immunizations for diseases such as measles, mumps, rubella, polio, and pertussis. This comprehensive review has prompted concerns about potential changes to long-standing immunization practices.
These developments occur amid broader debates over vaccine policies and their implications for public health. The outcomes of the ACIP's deliberations could significantly influence vaccination practices and disease prevention strategies nationwide.